HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshio Kuroki Selected Research

Collectins (Collectin)

9/2011Pulmonary collectins play distinct roles in host defense against Mycobacterium avium.
3/2010Pulmonary collectins protect macrophages against pore-forming activity of Legionella pneumophila and suppress its intracellular growth.
8/2007Pulmonary collectins in innate immunity of the lung.
1/2006Regulation of inflammation and bacterial clearance by lung collectins.
7/2003Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshio Kuroki Research Topics

Disease

9Inflammation (Inflammations)
11/2012 - 07/2003
5Neoplasms (Cancer)
11/2014 - 09/2005
5Pneumonia (Pneumonitis)
10/2010 - 01/2006
4Infections
01/2017 - 03/2010
3Adenocarcinoma of Lung
11/2017 - 12/2002
3Idiopathic Pulmonary Fibrosis
12/2014 - 01/2006
3Interstitial Lung Diseases (Interstitial Lung Disease)
08/2008 - 01/2006
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
09/2009 - 01/2006
2Carcinoma (Carcinomatosis)
05/2009 - 09/2005
2Vascular Diseases (Vascular Disease)
09/2007 - 01/2006
2Pleural Effusion (Pleural Effusions)
01/2006 - 12/2002
2Respiratory Tract Infections (Respiratory Tract Infection)
01/2006 - 02/2005
1Emphysema
09/2015
1Chronic Obstructive Pulmonary Disease (COPD)
09/2015
1Breast Neoplasms (Breast Cancer)
11/2013
1Septic Shock (Toxic Shock Syndrome)
03/2013
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2013
1Diabetes Complications
11/2012
1Persistent Infection
02/2012
1Lung Injury
10/2010
1Acquired Immunodeficiency Syndrome (AIDS)
06/2010
1Acute Lung Injury
09/2009
1Carcinogenesis
05/2009
1Acinar Cell Carcinoma
05/2009
1Colorectal Neoplasms (Colorectal Cancer)
05/2009
1Lung Neoplasms (Lung Cancer)
08/2008
1Atherosclerosis
03/2007
1Prostatitis
01/2007
1Pelvic Pain
01/2007
1Prostatic Neoplasms (Prostate Cancer)
03/2006
1Necrosis
01/2006
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2006
1Pulmonary Alveolar Proteinosis
01/2006
1Radiation Pneumonitis
01/2006
1Lung Diseases (Lung Disease)
01/2006
1Respiratory Tract Diseases (Respiratory Tract Disease)
09/2005
1Neoplasm Metastasis (Metastasis)
09/2005
1Virus Diseases (Viral Diseases)
02/2005
1Respiratory Syncytial Virus Infections
10/2003
1Glioma (Gliomas)
12/2002
1Alzheimer Disease (Alzheimer's Disease)
12/2002
1Brain Ischemia (Cerebral Ischemia)
12/2002
1Adenocarcinoma
12/2002

Drug/Important Bio-Agent (IBA)

8Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
09/2015 - 02/2005
8Proteins (Proteins, Gene)FDA Link
12/2014 - 10/2003
5Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA
11/2017 - 07/2003
5Biomarkers (Surrogate Marker)IBA
09/2015 - 01/2006
5Surface-Active Agents (Surfactants)IBA
12/2014 - 09/2005
5Collectins (Collectin)IBA
09/2011 - 07/2003
4Messenger RNA (mRNA)IBA
11/2012 - 12/2002
3Glycoproteins (Glycoprotein)IBA
09/2015 - 03/2007
3Polysaccharides (Glycans)IBA
09/2015 - 05/2009
3LipopolysaccharidesIBA
09/2009 - 12/2006
2Epidermal Growth Factor (EGF)IBA
11/2017 - 08/2008
2LectinsIBA
09/2015 - 11/2012
2FucoseIBA
09/2015 - 05/2009
2EnzymesIBA
09/2015 - 05/2009
2Neuregulin-1 (Neuregulin 1)IBA
11/2014 - 11/2013
2LigandsIBA
03/2013 - 08/2007
2Monoclonal AntibodiesIBA
01/2013 - 10/2010
2CollagenIBA
09/2007 - 01/2006
2EndotoxinsIBA
12/2006 - 12/2004
2CytokinesIBA
03/2006 - 02/2005
2Biological ProductsIBA
01/2006 - 02/2005
2Pulmonary Surfactants (Pulmonary Surfactant)IBA
01/2006 - 09/2005
1SmokeIBA
09/2015
1N-glycolylneuraminic acidIBA
01/2013
1GangliosidesIBA
01/2013
1Uroplakin IaIBA
11/2012
1Glucuronic Acid (Glucuronate)IBA
11/2012
1Indicators and Reagents (Reagents)IBA
04/2012
1AntigensIBA
02/2012
1LipidsIBA
09/2009
1Cadherins (E-Cadherin)IBA
05/2009
1AcetylglucosamineIBA
05/2009
1ErbB Receptors (EGF Receptor)IBA
08/2008
1Gefitinib (Iressa)FDA Link
08/2008
1Tyrosine Kinase InhibitorsIBA
08/2008
1AutoantibodiesIBA
09/2007
1Alanine-tRNA LigaseIBA
09/2007
1Toll-Like Receptors (Toll-Like Receptor)IBA
08/2007
1CalreticulinIBA
08/2007
1Cell Surface ReceptorsIBA
08/2007
1Scavenger Receptors (Scavenger Receptor)IBA
03/2007
1FluoroquinolonesIBA
01/2007
1Toll-Like Receptor 2IBA
03/2006
1ZymosanIBA
01/2006
1NF-kappa B (NF-kB)IBA
01/2006
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2006
1LactoferrinIBA
10/2003
1AnnexinsIBA
12/2002
1Ethanol (Ethyl Alcohol)IBA
12/2002
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
12/2002

Therapy/Procedure

3Therapeutics
11/2013 - 06/2010
1Intranasal Administration
08/2008